RE:RE:RE:RE:Am I the only one...Nope, plants aren't like machines. Clones grown next to eachother can have wildly different concentrations of certain metabolites. The plant I work on has ~30% variance in alkaloid between clones grown in vitro. Alkaloids, like THCs and CBDs, are specialized metabolites so their biosynthesis and deposition aren't as tightly regulated as auxin, for example. It amazes me that they can produce strains with THCs/CBDs levels within a smallish threshold. Aphria has shown that greenhouse vs indoors plays no role in this small variance, are you assume here. If you want to know why Aphria doesn't go full indoors look at your hydro bill.
doobiebaby wrote: Aces, thanks for that post. Never heard it stated that well before. I have wondered why Aphria is so reluctant to get into indoor grow since Bedrocan insists on it for consistency each and every time. I knew you had to control all the inputs to get the same output of harvest time after time. But I did not know about this certification difference which is critically important I would think from a medical perspective. Rec I don't think matters as much...although I think people want excellent consistency in the strains they are interested in...but for medical it has to be the same dose every time to be Pharma grade. Thanks for bringing up the certification issue.